World Kidney Day

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

Retrieved on:

Thursday, March 14, 2024

Chronic kidney disease, Type 2 diabetes, Disease, CKD, GFR, Risk, Kidney disease, Patient, Evaluation, Doctor of Philosophy, MD, Risk assessment, EGFR, World Kidney Day, Prognosis, FDA, Guideline, Nursing

LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD), published on March 13, 2024.

Key Points:

LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD), published on March 13, 2024.
In the release of the new guideline, timed to coincide with World Kidney Day on March 14, the KDIGO committee highlighted the role of risk prediction in guiding care for patients.
In this context, KidneyIntelX is recommended for use as an externally validated tool for predicting disease progression in people with CKD stages G1-G3.
In the KDIGO announcement of the publication of the 2024 CKD guideline, Adeera Levin MD, one of the Guideline Committee Co-Chairs said, “Recent advancements in GFR evaluation, risk prediction, and the arrival of novel treatments are poised to enhance CKD prognosis and management.

BLACK AMERICANS AT HIGHER RISK FOR KIDNEY FAILURE AS BLACK HEALTH MATTERS, NATIONAL KIDNEY FOUNDATION FIGHT FOR EQUITY DURING NATIONAL KIDNEY MONTH

Retrieved on:

Thursday, March 14, 2024

Health, BHM, NKF, Risk, Diabetes, Global health, Patient, National Kidney Foundation, EQUITY, ALL, Social media, Kidney failure, Kidney disease, Kidney, Chronic kidney disease, World Kidney Day, All, Pharmaceutical industry

NEW YORK, March 14, 2024 /PRNewswire/ -- Black Health Matters (BHM)– a leading nonprofit health advocacy organization that provides health and wellness information that is rooted in medical expertise to the Black community – is partnering with the National Kidney Foundation (NKF) to spread awareness about kidney equity during National Kidney Month. Observed in March each year, National Kidney Month aims to raise awareness about kidney health and chronic kidney disease. The month also includes World Kidney Day – a global health awareness day focusing on the importance of kidneys and the impact of kidney disease - which is observed March 14.

Key Points:

Observed in March each year, National Kidney Month aims to raise awareness about kidney health and chronic kidney disease.
The month also includes World Kidney Day – a global health awareness day focusing on the importance of kidneys and the impact of kidney disease - which is observed March 14.
NKF continues to fight to get Kidney Equity for All - a commitment to make a difference in ALL kidney patients' lives!
"As an organization that spotlights health disparities and the importance of health in the Black community, kidney health has become a silent epidemic in our community," said Roslyn Young-Daniels, President, and Founder of Black Health Matters.

Kidney Foundation Marks 60th Anniversary

Retrieved on:

Thursday, February 29, 2024

Learn more during Kidney Health Month in March

Key Points:

Montreal, Quebec--(Newsfile Corp. - February 29, 2024) - When the Kidney Foundation of Canada was launched in 1964, a person with kidney failure had very little hope of survival.
As we work to raise awareness of these vital organs, The Kidney Foundation is reflecting on the significant progress made in the past six decades to improve the quality of life and health outcomes of kidney patients.
"These advances are providing new hope for people diagnosed with kidney disease and those living with kidney failure."
The Kidney Foundation is ramping up advocacy efforts to ensure that every Canadian has access to the care they need to prevent or delay the progression of kidney disease.

World Kidney Day: A Bayer Survey Reveals Physicians Agree on Need for Earlier Testing and Increased Transparent Communication for People Diagnosed With Chronic Kidney Disease Associated With Type 2 Diabetes

Retrieved on:

Thursday, March 9, 2023

Today, World Kidney Day, results from a survey designed to gain a broader understanding of the attitudes and challenges faced by healthcare professionals (HCPs) in diagnosing, managing and treating people with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) were announced.

Key Points:

Today, World Kidney Day, results from a survey designed to gain a broader understanding of the attitudes and challenges faced by healthcare professionals (HCPs) in diagnosing, managing and treating people with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) were announced.
The survey was executed by Bayer and fielded in partnership with MedSurvey, a leading medical market research company.
Findings from the survey, which queried a total of 1,000 respondents made up of nephrologists, primary care physicians (PCPs), nurse practitioners (NPs) and physician assistants (PAs), revealed that HCPs believe care can be improved, with a collective acknowledgement that people with T2D need to be tested for CKD earlier and more often, despite results showing that guideline-driven tests to monitor for CKD and its progression, like urine albumin-creatinine ratio (uACR), a urine test to assess kidney function, are underutilized.1,2
When people are diagnosed with CKD associated with T2D, they often receive initial care from their PCP and are referred to a nephrologist (kidney specialists), only after their CKD has progressed.3
Survey results also revealed that PCPs and nephrologists have differing opinions on who should be the lead medical professional coordinating treatment and management, resulting in a significant number of patients not being referred to nephrologists earlier, despite the majority of HCPs surveyed agreeing that nephrologists need to be brought in sooner.1
“Research has shown that co-management between a primary care physician and a nephrologist is associated with improved quality of care, delayed dialysis and more frequent testing, but we wanted to more deeply understand some of the challenges the treatment team faced in an effort to incite conversations about how we can improve on them,” said German Guerrero, M.D., Executive Medical Director, Cardiorenal, Bayer.4 “At Bayer, we are working to ensure people with chronic kidney disease associated with type 2 diabetes receive optimal care that ultimately leads to earlier diagnosis and treatment and better outcomes.”
The majority of HCPs surveyed (80% PCPs, 88% nephrologists, 88% NPs/PAs) agree the medical community could do better and diagnose CKD in people with T2D earlier1
While a majority of HCPs are using estimated glomerular filtration rate (eGFR) blood tests to assess kidney function at least once every few months (62% PCPs, 80% nephrologists, 77% NPs/PAs), uACR tests are significantly underutilized (30% PCPs, 57% nephrologists, 38% NPs/PAs), clashing with guideline recommendations to test more frequently1
The vast majority of HCPs (77% PCPs, 90% nephrologists, 89% NPs/PAs) agree nephrologists need to be brought in earlier, yet 88% of PCPs may choose not to refer people with CKD to a nephrologist; the top reasons include1:
The top challenges HCPs face when co-managing patients include1:
“These findings reinforce the importance of our commitment to identifying resources and programs aimed at better understanding the real-world management of chronic kidney disease and expanding screening and early care management,” said Dr. Guerrero.
“Together—with healthcare professionals and the broader kidney community—we have an opportunity to improve the diagnosis and management of chronic kidney disease to truly advance care.”

World Kidney Day: The COVID-19 Pandemic Catalyzes Need for Adequate Care for People Living With Kidney Disease

Retrieved on:

Wednesday, March 8, 2023

Nature, Diagnosis, Health, Kidney disease, International Society, National Kidney Foundation Singapore, WKD, Policy, ISN, COVID-19, World Kidney Day, Pharmaceutical industry

BRUSSELS, March 8, 2023 /PRNewswire/ -- More than 850 million people worldwide are living with kidney disease and are particularly affected by disastrous events as their ability to access appropriate care, complex and multi-faceted in nature, may be hindered.

Key Points:

BRUSSELS, March 8, 2023 /PRNewswire/ -- More than 850 million people worldwide are living with kidney disease and are particularly affected by disastrous events as their ability to access appropriate care, complex and multi-faceted in nature, may be hindered.
On March 9, 2023, the World Kidney Day call to action is "Kidney Health for All: Preparing for the unexpected, supporting the vulnerable!"
This call to action is for the whole of society, including policymakers, health care services, governments, industry, as well as people living with kidney disease and their carers, to be well prepared for unexpected events to avoid any disruption in access to diagnosis, treatment, and care.
Read the full press release here: https://www.worldkidneyday.org/resource-library/wkd-press-release-2023/
"The COVID-19 pandemic has highlighted the challenges faced by healthcare systems to provide essential health services and a policy deficit in managing consistent access to care.

World Kidney Day: The COVID-19 Pandemic Catalyzes Need for Adequate Care for People Living With Kidney Disease

Retrieved on:

Wednesday, March 8, 2023

Nature, Diagnosis, Health, Kidney disease, International Society, National Kidney Foundation Singapore, WKD, Policy, ISN, COVID-19, World Kidney Day, Pharmaceutical industry

BRUSSELS, March 8, 2023 /PRNewswire/ -- More than 850 million people worldwide are living with kidney disease and are particularly affected by disastrous events as their ability to access appropriate care, complex and multi-faceted in nature, may be hindered.

Key Points:

BRUSSELS, March 8, 2023 /PRNewswire/ -- More than 850 million people worldwide are living with kidney disease and are particularly affected by disastrous events as their ability to access appropriate care, complex and multi-faceted in nature, may be hindered.
On March 9, 2023, the World Kidney Day call to action is "Kidney Health for All: Preparing for the unexpected, supporting the vulnerable!"
This call to action is for the whole of society, including policymakers, health care services, governments, industry, as well as people living with kidney disease and their carers, to be well prepared for unexpected events to avoid any disruption in access to diagnosis, treatment, and care.
Read the full press release here: https://www.worldkidneyday.org/resource-library/wkd-press-release-2023/
"The COVID-19 pandemic has highlighted the challenges faced by healthcare systems to provide essential health services and a policy deficit in managing consistent access to care.

The National Kidney Foundation and Healthy.io partner to Increase Access to Testing for Detection of Kidney Disease

Retrieved on:

Wednesday, March 8, 2023

BOSTON, March 8, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF), a non-profit health organization dedicated to the awareness, prevention, and treatment of kidney disease, and Healthy.io, the global leader in transforming the smartphone camera into a clinical-grade medical device, today announced a new effort to promote detection of chronic kidney disease (CKD). Through their partnership, the NKF and Healthy.io will offer Healthy.io's Minuteful Kidney™ at-home kidney test, free of charge, to people who are at risk for kidney disease.

Key Points:

Through their partnership, the NKF and Healthy.io will offer Healthy.io's Minuteful Kidney™ at-home kidney test, free of charge, to people who are at risk for kidney disease.
"This is particularly concerning when it comes to annual urine testing for kidney disease.
campaign aims to raise awareness of the importance of early kidney disease detection," said Joseph Vassalotti, MD, Chief Medical Officer of the National Kidney Foundation.
Working to promote kidney health equity for all and increasing access to early detection are top priorities for NKF.

24-Year-Old Kibow Biotech/Pharmaceuticals Company of Pennsylvania, USA Supports World Kidney Day 2022 on its Mission "Kidney Health for All."

Retrieved on:

Thursday, March 10, 2022

NEWTOWN SQUARE, Pa., March 10, 2022 /PRNewswire/ --Kibow Biotech is pleased to announce that it is joining and celebrating World Kidney Day (WKD) on March 10, 2022.

Key Points:

NEWTOWN SQUARE, Pa., March 10, 2022 /PRNewswire/ --Kibow Biotech is pleased to announce that it is joining and celebrating World Kidney Day (WKD) on March 10, 2022.
Its theme is Kidney Health for All, with an effective social media campaign and financial support towards its activities.
Kidney disease is now taking center stage on awareness and a burden to healthcare expenditure ( News: CKD moves to center stage with launch of Kidney Care Choices model ).
Chronic kidney disease (CKD) affects about 10 % of the adult population worldwide and 15% of the US population.

Dialyze Direct Supports World Kidney Day and Raises Awareness of Improved Kidney Care for Geriatric Patients in Skilled Nursing Facilities

Retrieved on:

Thursday, March 10, 2022

On World Kidney Day, to support the theme of Bridge the Knowledge Gap to Better Kidney Care, Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), joins the nephrology and diabetes communities in raising awareness about improved dialysis for geriatric patients.

Key Points:

On World Kidney Day, to support the theme of Bridge the Knowledge Gap to Better Kidney Care, Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), joins the nephrology and diabetes communities in raising awareness about improved dialysis for geriatric patients.
Our mission is to lead the way in offering unparalleled kidney care for geriatric patients by healing both people and systems, said Josh Rothenberg, President and Co-Founder of Dialyze Direct.
Dialyze Direct was founded on the belief that dialysis is not a one-size-fits-all care regimen; rather, each patient deserves treatment tailored to their individual needs.
For more information about World Kidney Day and kidney care, follow these links:

Fresenius Medical Care North America Donates $250,000 to Boys & Girls Clubs of America to Provide Kidney Health Education

Retrieved on:

Thursday, March 10, 2022

Additionally, in 20 Boys & Girls Clubs across the nation, FMCNA employees will educate 2,000 youth about the importance of their kidney health.

Key Points:

Additionally, in 20 Boys & Girls Clubs across the nation, FMCNA employees will educate 2,000 youth about the importance of their kidney health.
In these locations, FMCNA employees will introduce kidney health education with the help of The Kidney Kid, a superhero who promotes kidney health through an 'edutainment' (education + entertainment) program.
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
For 160 years, Boys & Girls Clubs of America ( BGCA.org ) has provided a safe place for kids and teens to learn and grow.